TI
ACOR

Telemetry Investments’s Acorda Therapeutics ACOR Stock Holding History

Telemetry Investments’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$102K Buy
+6,625
New +$77.2K 0.16% 88

Other funds holding ACOR

DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Saltoro Capital Dallas, Texas $30K AUM 24.79% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Telemetry Investments's ACOR Position: Q4 2022 in Review

Telemetry Investments opened a new position in Acorda Therapeutics (ACOR) in Q4 2022: 6,625 shares worth $102K. The stake represents 0.16% of the portfolio and ranks #88 among its holdings.

34 funds tracked by Wall St. Rank hold ACOR as of Q4 2022.

  • Telemetry Investments held 6,625 shares of Acorda Therapeutics worth $102K as of Q4 2022.
  • Acorda Therapeutics was a new Telemetry Investments position in Q4 2022.
  • Acorda Therapeutics made up 0.16% of Telemetry Investments's portfolio in Q4 2022, its #88 holding.
  • 34 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.